Serotonin syndrome due to co-administration of linezolid and methadone

Infez Med. 2017 Sep 1;25(3):263-266.

Abstract

Serotonin syndrome (SS), a potentially life-threatening adverse drug reaction caused by excessive serotonergic agonism in central and peripheral nervous system serotonergic receptors, may be caused by a single drug or a combination of drugs with serotonergic activity. The syndrome results in a variety of mental, autonomic and neuromuscular changes, which can range in severity from mild to life-threatening. To our knowledge, we present the first reported case of SS associated with linezolid and methadone with a brief review of the literature.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • Drug Synergism
  • Drug Therapy, Combination
  • HIV Infections / complications
  • Humans
  • Linezolid / administration & dosage
  • Linezolid / adverse effects*
  • Linezolid / pharmacokinetics
  • Linezolid / therapeutic use
  • Male
  • Methadone / administration & dosage
  • Methadone / adverse effects*
  • Methadone / pharmacokinetics
  • Methadone / therapeutic use
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification
  • Monoamine Oxidase Inhibitors / adverse effects
  • Monoamine Oxidase Inhibitors / pharmacokinetics
  • Opiate Substitution Treatment
  • Selective Serotonin Reuptake Inhibitors / adverse effects
  • Selective Serotonin Reuptake Inhibitors / pharmacokinetics
  • Serotonin Syndrome / etiology*
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Substance Abuse, Intravenous / complications
  • Substance Abuse, Intravenous / drug therapy

Substances

  • Anti-HIV Agents
  • Monoamine Oxidase Inhibitors
  • Serotonin Uptake Inhibitors
  • Linezolid
  • Methadone